Abbott said that an ongoing multisite clinical study indicated that its rapid COVID-19 test was accurate when detecting the virus nearly 95% of the time. Abbott said that an ongoing multisite ...

The rapid tests are produced by Abbott Labs and are called the BinaxNOW COVID-19 Ag Card. There was a prior Abbott rapid test called the ID Now, which had been criticised in some studies for an ...

Abbott Laboratories ABT faced industry-wide challenges that exerted pressure on its profit margins. Factors such as rising ...

Isothermal nucleic acid amplification technology market advances through rapid diagnostics, innovative integration, and ...

Abbott Laboratories shares were down Wednesdsay morning after the company laid out guidance for the first quarter of the year that was below market expectations.The stock was down 0.2% Wednesday while ...

Abbott Laboratories (NYSE:ABT) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion. Organic sales growth for the underlying base business ...

Abbott Laboratories is forecasting lower ... but the company saw increased demand for rapid flu, strep and RSV tests.